Literature DB >> 16785492

Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani.

Lucia E Rosas1, Heidi M Snider, Joseph Barbi, Anjali A Satoskar, Geanncarlo Lugo-Villarino, Tracy Keiser, Tracy Papenfuss, Joan E Durbin, Danuta Radzioch, Laurie H Glimcher, Abhay R Satoskar.   

Abstract

T-bet and STAT1 regulate IFN-gamma gene transcription in CD4+ T cells, which mediate protection against Leishmania. Here we show that T-bet and STAT1 are required for the induction of an efficient Th1 response during Leishmania donovani infection, but they play distinct roles in determining disease outcome. Both STAT1(-/-) and T-bet(-/-) mice failed to mount a Th1 response, but STAT1(-/-) mice were highly resistant to L. donovani and developed less immunopathology, whereas T-bet(-/-) mice were highly susceptible and eventually developed liver inflammation. Adoptive cell transfer studies showed that RAG2(-/-) recipients receiving STAT1(+/+) or STAT1(-/-) T cells developed comparable liver pathology, but those receiving STAT1(-/-) T cells were significantly more susceptible to infection. These unexpected findings reveal distinct roles for T-bet and STAT1 in mediating host immunity and liver pathology during visceral leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785492     DOI: 10.4049/jimmunol.177.1.22

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

2.  Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.

Authors:  Henry W Murray; Andrew D Luster; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

3.  Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.

Authors:  Shashi Bhushan Chauhan; Rebecca Faleiro; Rajiv Kumar; Susanna Ng; Bhawana Singh; Om Prakash Singh; Siddharth Sankar Singh; Fiona Amante; Fabian de Labastida Rivera; Madhukar Rai; Jaya Chakravarty; David Sacks; Susanne Nylen; Shyam Sundar; Christian Engwerda
Journal:  J Infect Dis       Date:  2019-06-05       Impact factor: 5.226

Review 4.  Cytokines and their STATs in cutaneous and visceral leishmaniasis.

Authors:  Hannah E Cummings; Rashmi Tuladhar; Abhay R Satoskar
Journal:  J Biomed Biotechnol       Date:  2010-03-15

5.  T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation.

Authors:  Laura I Rutitzky; Patrick M Smith; Miguel J Stadecker
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

6.  T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.

Authors:  Amanda A Melillo; Oded Foreman; Catharine M Bosio; Karen L Elkins
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

7.  Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection.

Authors:  Joseph Barbi; Heidi M Snider; Neeti Bhardwaj; Claudio M Lezama-Dávila; Joan E Durbin; Abhay R Satoskar
Journal:  FASEB J       Date:  2009-07-29       Impact factor: 5.191

8.  T-bet-dependent regulation of CD8+ T-cell expansion during experimental Trypanosoma cruzi infection.

Authors:  Dustin Cobb; Siqi Guo; Ana M Lara; Patricio Manque; Gregory Buck; Ronald B Smeltz
Journal:  Immunology       Date:  2009-08-04       Impact factor: 7.397

Review 9.  Trypanosoma cruzi parasites fight for control of the JAK-STAT pathway by disarming their host.

Authors:  Philipp Stahl; Ralph T Schwarz; Françoise Debierre-Grockiego; Thomas Meyer
Journal:  JAKSTAT       Date:  2015-02-03

10.  A partial form of recessive STAT1 deficiency in humans.

Authors:  Ariane Chapgier; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Emmanuelle Jouanguy; Diana Averbuch; Jacqueline Feinberg; Shen-Ying Zhang; Jacinta Bustamante; Guillaume Vogt; Julien Lejeune; Eleonore Mayola; Ludovic de Beaucoudrey; Laurent Abel; Dan Engelhard; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.